[go: up one dir, main page]

BRPI0606373A2 - composição de xarope compreendendo dexibuprofeno como ingrediente ativo e método para a preparação da mesma - Google Patents

composição de xarope compreendendo dexibuprofeno como ingrediente ativo e método para a preparação da mesma

Info

Publication number
BRPI0606373A2
BRPI0606373A2 BRPI0606373-0A BRPI0606373A BRPI0606373A2 BR PI0606373 A2 BRPI0606373 A2 BR PI0606373A2 BR PI0606373 A BRPI0606373 A BR PI0606373A BR PI0606373 A2 BRPI0606373 A2 BR PI0606373A2
Authority
BR
Brazil
Prior art keywords
dexibuprofen
active ingredient
preparing
syrup composition
ranging
Prior art date
Application number
BRPI0606373-0A
Other languages
English (en)
Inventor
Jong Soo Woo
Hong Gi Yi
Ju Nam Jin
Original Assignee
Hanmi Pharm Ind Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Hanmi Pharm Ind Co Ltd filed Critical Hanmi Pharm Ind Co Ltd
Publication of BRPI0606373A2 publication Critical patent/BRPI0606373A2/pt

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0087—Galenical forms not covered by A61K9/02 - A61K9/7023
    • A61K9/0095—Drinks; Beverages; Syrups; Compositions for reconstitution thereof, e.g. powders or tablets to be dispersed in a glass of water; Veterinary drenches
    • B—PERFORMING OPERATIONS; TRANSPORTING
    • B02—CRUSHING, PULVERISING, OR DISINTEGRATING; PREPARATORY TREATMENT OF GRAIN FOR MILLING
    • B02C—CRUSHING, PULVERISING, OR DISINTEGRATING IN GENERAL; MILLING GRAIN
    • B02C18/00—Disintegrating by knives or other cutting or tearing members which chop material into fragments
    • B02C18/06—Disintegrating by knives or other cutting or tearing members which chop material into fragments with rotating knives
    • B02C18/16—Details
    • B02C18/18—Knives; Mountings thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • B—PERFORMING OPERATIONS; TRANSPORTING
    • B02—CRUSHING, PULVERISING, OR DISINTEGRATING; PREPARATORY TREATMENT OF GRAIN FOR MILLING
    • B02C—CRUSHING, PULVERISING, OR DISINTEGRATING IN GENERAL; MILLING GRAIN
    • B02C18/00—Disintegrating by knives or other cutting or tearing members which chop material into fragments
    • B02C18/06—Disintegrating by knives or other cutting or tearing members which chop material into fragments with rotating knives
    • B02C18/16—Details
    • B02C18/22—Feed or discharge means
    • B02C18/2216—Discharge means
    • B—PERFORMING OPERATIONS; TRANSPORTING
    • B02—CRUSHING, PULVERISING, OR DISINTEGRATING; PREPARATORY TREATMENT OF GRAIN FOR MILLING
    • B02C—CRUSHING, PULVERISING, OR DISINTEGRATING IN GENERAL; MILLING GRAIN
    • B02C18/00—Disintegrating by knives or other cutting or tearing members which chop material into fragments
    • B02C18/06—Disintegrating by knives or other cutting or tearing members which chop material into fragments with rotating knives
    • B02C18/16—Details
    • B02C18/24—Drives
    • B—PERFORMING OPERATIONS; TRANSPORTING
    • B09—DISPOSAL OF SOLID WASTE; RECLAMATION OF CONTAMINATED SOIL
    • B09B—DISPOSAL OF SOLID WASTE NOT OTHERWISE PROVIDED FOR
    • B09B3/00—Destroying solid waste or transforming solid waste into something useful or harmless

Landscapes

  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Food Science & Technology (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Epidemiology (AREA)
  • Rheumatology (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pain & Pain Management (AREA)
  • Environmental & Geological Engineering (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)

Abstract

COMPOSIçãO DE XAROPE COMPREENDENDO DEXIBUPROFENO COMO INGREDIENTE ATIVO E MéTODO PARA A PREPARAçãO DA MESMA. Uma composição de xarope de dexibuprofeno compreendendo dexibuprofeno ((S)-ibuprofeno) tendo um tamanho médio de partícula variando de 10 a 300 <109>m como ingrediente ativo, que não contém glicerina e tem uma viscosidade variando de 500 a 3.000 cps e pH variando de 3,0 a 6,0, mostra segurança, uniformidade de eficácia e sabor aperfeiçoados.
BRPI0606373-0A 2005-01-03 2006-01-03 composição de xarope compreendendo dexibuprofeno como ingrediente ativo e método para a preparação da mesma BRPI0606373A2 (pt)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
KR1020050000222A KR100678837B1 (ko) 2005-01-03 2005-01-03 활성 성분으로 덱시부프로펜을 함유하는 시럽제 조성물 및그의 제조 방법
PCT/KR2006/000016 WO2006073257A1 (en) 2005-01-03 2006-01-03 Syrup composition comprising dexibupropen as an active ingredient and method for the preparation thereof

Publications (1)

Publication Number Publication Date
BRPI0606373A2 true BRPI0606373A2 (pt) 2009-06-23

Family

ID=36647725

Family Applications (1)

Application Number Title Priority Date Filing Date
BRPI0606373-0A BRPI0606373A2 (pt) 2005-01-03 2006-01-03 composição de xarope compreendendo dexibuprofeno como ingrediente ativo e método para a preparação da mesma

Country Status (13)

Country Link
US (1) US20080014223A1 (pt)
EP (1) EP1845941A4 (pt)
JP (1) JP2008526736A (pt)
KR (1) KR100678837B1 (pt)
CN (1) CN101098680A (pt)
AU (1) AU2006204228B2 (pt)
BR (1) BRPI0606373A2 (pt)
CA (1) CA2592591C (pt)
IL (1) IL184319A (pt)
MX (1) MX2007008032A (pt)
NZ (1) NZ556774A (pt)
RU (1) RU2382636C2 (pt)
WO (1) WO2006073257A1 (pt)

Families Citing this family (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IL169678A (en) 2005-07-14 2010-11-30 Innova Sa Sweetener compositions
KR101297354B1 (ko) * 2011-01-13 2013-08-19 동광제약주식회사 안정하고 불쾌한 맛이 차폐된 덱시부프로펜을 함유한 투명한 시럽 조성물
CN104173277A (zh) * 2013-05-23 2014-12-03 上海博悦生物科技有限公司 一种右旋布洛芬口服液体制剂及其制备方法
US20160242439A1 (en) 2014-04-04 2016-08-25 Douxmatok Ltd Method for producing sweetener compositions and sweetener compositions
US10207004B2 (en) 2014-04-04 2019-02-19 Douxmatok Ltd Method for producing sweetener compositions and sweetener compositions
US10231476B2 (en) 2014-04-04 2019-03-19 Douxmatok Ltd Sweetener compositions and foods, beverages, and consumable products made thereof
US10266750B2 (en) * 2015-09-02 2019-04-23 Chevron U.S.A. Inc. Oil recovery compositions and methods thereof
CN105935445B (zh) * 2016-03-28 2019-02-01 赤峰赛林泰药业有限公司 含2-(-4-异丁基苯基)丙酸右旋物的药物组合物及其制备方法
RU2713303C2 (ru) * 2018-04-10 2020-02-04 Общество с ограниченной ответственностью "Внешторг Фарма" Биологически активная добавка в виде сиропа с повышенной микробиологической устойчивостью
CN112516083B (zh) * 2020-12-15 2023-02-28 太阳升(亳州)生物医药科技有限公司 布洛芬混悬液及其制备方法

Family Cites Families (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4788220A (en) * 1987-07-08 1988-11-29 American Home Products Corporation (Del.) Pediatric ibuprofen compositions
IT1264856B1 (it) * 1993-06-21 1996-10-17 Zambon Spa Composizione farmaceutica ad attivita' analgesica
FR2713931B1 (fr) * 1993-12-20 1996-04-05 Laurence Paris Nouvelles compositions pharmaceutiques liquides à base d'ibuprofène et leur procédé de préparation.
US5712310A (en) 1996-06-14 1998-01-27 Alpharma Uspd, Inc. Suspension of substantially water-insoluble drugs and methods of their manufacture
JP2003171314A (ja) * 2001-09-26 2003-06-20 Lion Corp 内服液剤組成物
US6551615B1 (en) * 2001-10-18 2003-04-22 M/S. Strides Arcolab Limited Dexibuprofen-containing soft gelatin capsules and process for preparing the same
US7101572B2 (en) * 2001-12-07 2006-09-05 Unilab Pharmatech, Ltd. Taste masked aqueous liquid pharmaceutical composition
US7300670B2 (en) * 2002-04-03 2007-11-27 Unilab Pharmatech, Ltd. Oral suspension formulation
KR100494096B1 (ko) 2002-08-05 2005-06-13 한미약품 주식회사 감기약 성분을 함유하는 경구투여용 조성물
KR100507771B1 (ko) 2002-11-08 2005-08-17 한미약품 주식회사 난용성 감기약 활성 성분의 경구투여용 조성물 및 그의제조 방법
KR100509432B1 (ko) 2002-12-13 2005-08-22 주식회사 동구제약 Ｓ(+)-이부프로펜을 함유한 시럽제 조성물 및 그의 제조방법
KR100509433B1 (ko) 2003-02-05 2005-08-22 주식회사 동구제약 Ｓ(+)-이부프로펜의 연질캅셀제 조성물 및 그의 제조방법

Also Published As

Publication number Publication date
JP2008526736A (ja) 2008-07-24
CN101098680A (zh) 2008-01-02
KR100678837B1 (ko) 2007-02-05
IL184319A (en) 2014-11-30
CA2592591C (en) 2012-02-14
US20080014223A1 (en) 2008-01-17
CA2592591A1 (en) 2006-07-13
EP1845941A1 (en) 2007-10-24
MX2007008032A (es) 2007-08-21
RU2007129728A (ru) 2009-02-10
EP1845941A4 (en) 2008-10-08
NZ556774A (en) 2011-02-25
IL184319A0 (en) 2007-10-31
KR20060079880A (ko) 2006-07-07
RU2382636C2 (ru) 2010-02-27
WO2006073257A1 (en) 2006-07-13
AU2006204228B2 (en) 2009-12-17
AU2006204228A1 (en) 2006-07-13

Similar Documents

Publication Publication Date Title
MX2009004551A (es) Metodo de preparacion de microcapsulas de liberacion sostenida con buena propiedad inhibitoria de aparicion repentina inicial y las microcapsulas del mismo.
CO5570656A2 (es) Liberacin controlada de una sustancia activa a un entorno rico en grasa
TW200735773A (en) Insecticidal compositions with improved activity
CL2015001973A1 (es) (divisional de la sol. 1567-2013) combinaciones de principios activos que comprenden piridiletilbenzamidas y otros principios activos.
BR112013028907A2 (pt) conjugados de proteína-agente ativo e método para preparar os mesmos
WO2009142719A3 (en) Tympanic membrane permeating ear drops and uses thereof
NO20092998L (no) Flytende formuleringer, som danner dermal film, for frigjoring av legemidler til huden
BRPI0606373A2 (pt) composição de xarope compreendendo dexibuprofeno como ingrediente ativo e método para a preparação da mesma
CU20060153A7 (es) Nueva forma cristalina v de agomelatina, procedimiento para su preparación y composiciones farmacéuticas que las contienen
UA102254C2 (ru) Жидкий состав для деферипрона с приятным вкусом
CL2004000899A1 (es) Composicion farmaceutica que contiene la sal sodica de telmisartan y un agente diuretico y procedimiento de preparacion.
AR018357A1 (es) Acido petroselinico en una composicion y en un metodo para reducir o eliminar la irritacion o la picazon de la piel inducida por los alfa-hidroxiacidos
ATE522204T1 (de) Beschichtete pellets
AR054939A1 (es) Metodos para aplicar formulaciones antimicrobianas sobre alimentos
AR075274A1 (es) Agente de tratamiento de semillas y metodo para proteger una planta
CR20110226A (es) Composición para tratar enfermedad
ECSP034915A (es) Formulacion farmaceutica de sabor enmascarado y procedimiento para su preparacion
EA201070806A1 (ru) Состав медленного высвобождения на основе ассоциации гликогена и альгината
CR9839A (es) Composicion farmaceutica fotoestable que contiene brivudina para el tratamiento de la queratitis herpetica
IL186058A0 (en) Polymorphs of 3-0-(3&#39;,3&#39; -dimethylsuccinyl) betulinic acid di-n-methyl-d-glucamine salt
MXPA02008270A (es) Transportador de lipidos.
EP3295932A3 (en) Stable odf composition containing hardly soluble therapeutic agent
C Almeida et al. Contributions of ultrastructural studies to the cell biology of trypanosmatids: targets for anti-parasitic drugs
BRPI0506630A (pt) composição de liberação controlada e método para administrar um medicamento aquoso transmucosal de liberação controlada
EA201000585A1 (ru) Многочастичная матричная система, содержащая галантамин

Legal Events

Date Code Title Description
B25A Requested transfer of rights approved

Owner name: HANMI HOLDINGS CO., LTD. (KR)

Free format text: TRANSFERIDO DE: HANMI PHARM. CO., LTD.

B25D Requested change of name of applicant approved

Owner name: HANMI SCIENCE CO., LTD. (KR)

B25G Requested change of headquarter approved

Owner name: HANMI SCIENCE CO., LTD. (KR)

B06F Objections, documents and/or translations needed after an examination request according [chapter 6.6 patent gazette]
B07D Technical examination (opinion) related to article 229 of industrial property law [chapter 7.4 patent gazette]
B07E Notification of approval relating to section 229 industrial property law [chapter 7.5 patent gazette]
B07A Application suspended after technical examination (opinion) [chapter 7.1 patent gazette]
B09B Patent application refused [chapter 9.2 patent gazette]
B09B Patent application refused [chapter 9.2 patent gazette]

Free format text: MANTIDO O INDEFERIMENTO UMA VEZ QUE NAO FOI APRESENTADO RECURSO DENTRO DO PRAZO LEGAL